CompletedNo phase
Early Detection of HCV in Injection Drug Users
Key facts
- Who runs it
- Institute of Health Information and Statistics of the Czech Republic
- Where
- Czechia18 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 2,776 people enrolled
- Started
- 15 Dec 2023
- Ended
- 31 Dec 2025
- Type of study
- Observational
- Treatments tested
- Hepatitis C antibody (anti-HCV) test
- Hepatitis C RNA test and genotype test
- Record updated
- 6 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- age 18+
- an active injecting drug user or have used injecting drugs at any time in the past
Who cannot take part
- not agreeing to participate in the project
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The project is a national, prospective, multicenter, non-interventional pilot project of screening HCV in PWID in the Czech Republic.
Read full original descriptionShow less
The main goal of the project is to methodically prepare, implement and evaluate a pilot project that will verify the suitability of the proposed procedure of early detection of Hepatitis C and setting up and testing new methods and implementation into the system of social health care.
The group in the trial
- People who inject drugs
Treatment: Hepatitis C antibody (anti-HCV) test and Hepatitis C RNA test and genotype test
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Early Detection of Hepatitis C in Injection Drug Users
- Record updated
- 6 November 2026